Non-typeable Haemophilus influenzae (NTHi) is a common opportunistic bacterial pathogen that primarily infects the respiratory mucosa. This study was conducted to assess clinical and microbiological data related to disease severity in patients with lower respiratory tract infections caused by NTHi in a tertiary care hospital in Mexico. NTHi isolates were subjected to serotyping, antimicrobial susceptibility evaluationand analyses of b-lactamase production, genetic relatednessand biofilm formation. Clinical and demographic data were retrieved from patients' records. The mean age of the patients was 40.3 years; the majority (n=44, 72.1 %) were male. The main comorbidities were arterial hypertension (n=22, 36.1 %) and diabetes mellitus (n=17, 27.9 %). NTHi isolates (n=98) were recovered from tracheal aspirate (n=57, 58.2 %), sputum (n=26, 26.5 %)and bronchial aspirate (n=15, 15.3 %) specimens. Low resistance to cefotaxime (n=0, 0.0 %), rifampin (n=1, 1.1 %) and chloramphenicol (n=3, 3.2 %) and greater resistance to ampicillin (n=30, 32.3 %) and trimethoprim-sulfamethoxazole (n=49, 52.7 %) were detected. bLactamase production was found in 17 (17.3 %) isolates. Isolates displayed high genetic diversity, and only 10 (10.2 %) were found to be biofilm producers. The antimicrobial susceptibility patterns of biofilm-producing and non-producing isolates did not differ. Biofilm production was associated with prolonged hospital stay (P=0.05). Lower respiratory NTHi isolates from Mexico showed low antimicrobial resistance and weak biofilm production. Younger
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INTRODUCTION
Non-typeable Haemophilus influenzae (NTHi) are small, fastidious non-encapsulated Gram-negative coccobacilli that colonize the respiratory tract and act as an opportunistic pathogen in humans. NTHi are one of the leading causes of mucosal infections, such as otitis media in infants and children, sinusitis in children and adults, communityacquired pneumonia (CAP) in adults and exacerbations in adults with chronic obstructive pulmonary disease (Murphy, 2003; Murphy et al., 2004; Mizrahi et al., 2014; Van Eldere et al., 2014) . Several studies have established NTHi as a causal agent of lower respiratory tract infections. They have been detected in 15 to 40 % of lung aspirate cultures in children with lower respiratory tract infections (ranging from tracheobronchitis to CAP) and in 20 to 94 % of bronchoalveolar lavage samples in children with CAP (Van Eldere et al., 2014) . In an antimicrobial surveillance programme conducted in the USA in 2009 to 2012, H. influenzae was the ninth most common Gram-negative organism isolated from patients hospitalized with pneumonia (Sader et al., 2014) .
The incidence of invasive NTHi has been increasing worldwide, with perinatal infants, young children and elderly people most at risk. Infections in patients with underlying comorbidities are commonly associated with high mortality.
Some mechanisms of resistance to antibiotics used in the treatment of H. influenzae infections, such as ampicillin, have been reported (Tristram et al., 2007) . b-Lactamase production in H. influenzae and NTHi remains the dominant resistance mechanism against b-lactams. The prevalence of b-lactamase in NTHi differs significantly among global regions. In the past decade, studies have reported percentages of b-lactamase-positive NTHi falling between 10 and 25 % in most regions (Alpuche et al., 2007) .
Several studies have shown that NTHi form biofilms in vivo and in vitro (Murphy & Kirkham, 2002; Swords, 2012; Langereis & Hermans, 2013; Mizrahi et al., 2014; Puig et al., 2014a) . A biofilm is a community of micro-organisms adhering to a surface and enclosed in a self-produced extracellular matrix. This structure protects against external aggression, such as the host immune system and antibiotic treatment (Costerton et al., 1999) . Several studies have implicated the presence of biofilm in persistent infections caused by H. influenzae (Swords, 2012) , highlighting the possible role of such biofilms as a cause of otitis media (Murphy, 2003) .
Nevertheless, few reports have addressed the prognostic factors of NTHi in lower respiratory infections. The aim of this study was to assess the clinical and microbiological data related to disease severity in patients with lower respiratory tract infections caused by NTHi from a tertiary care hospital in Mexico.
METHODS
Ethics statement. The local ethics committee (Comit e de Ética y Comit e de Investigación, Facultad de Medicina y Hospital 'Dr Jos e Eleuterio Gonz alez,' Universidad Autónoma de Nuevo León, Mexico) approved this study (reference no. IF15-011). The committee waived the requirement for informed consent because no intervention was involved and no patient-identifying information was included.
Clinical isolates and study population. This prospective study involved patients with lower respiratory tract infections caused by H. influenzae who were treated in the Hospital Universitario 'Dr Jos e Eleuterio Gonz alez' between September 2012 and March 2015. The hospital is a 460-bed tertiary care hospital in Monterrey, Mexico. This study was conducted in the adult medical and surgical intensive care units (ICUs; 20-bed combined unit) with representation of one isolate per patient. We retrieved demographic and clinical data from patients' charts to designate Acute Physiology and Chronic Health Evaluation (APACHE) II scores (Knaus et al., 1985) .
Clinical samples were obtained according to the standard protocol (Jorgensen et al., 2015) . Isolates were identified as H. influenzae by colony morphology, Gram stain and growth on chocolate agar supplemented with factors X and V. Isolates were confirmed using Sensititre panels (TREK Diagnostic Systems) according to the manufacturer's instructions. Satellitism tests on blood agar and in nutritive agar were performed. Serotyping for a-f serotypes was conducted by slide agglutination with H. influenzae polyvalent and monovalent antisera (Difco Laboratories). All H. influenzae isolates were stored at -80 C until further use.
Antimicrobial susceptibility and b-lactamase production. Susceptibility testing of H. influenzae was performed using the broth microdilution test with haemophilus test medium broth (Difco Laboratories) according to the Clinical and Laboratory Standards Institute (CLSI) procedures (CLSI, 2015a). The antibiotics and concentration range tested were as follows: ampicillin (0.06-64 µg ml ) and trimethoprim-sulfamethoxazole (0.03/0.6-32/608 µg ml À1 ), all from MP Biomedicals. Results were interpreted according to the CLSI criteria (CLSI, 2015b) . All H. influenzae isolates were screened for b-lactamase production using the nitrocefin test (BBL DrySlide Nitrocefin; Becton Dickinson) according to the manufacturer's instructions.
Molecular typing. The genetic relatedness of a randomly selected sample of NTHi isolates was analysed by PFGE as described previously by Puig et al. (2013) , with modifications. DNA was digested with the restriction enzyme SmaI, and electrophoresis was performed using the CHEF-DR III system (Bio-Rad) at 6 V cm
À1
, with linear switching interval ramps from 1.0 to 30 s for 19 h at 14 C. Band patterns were compared visually after ethidium bromide staining, and interpretation was based on the criteria of Tenover et al. (1995) . Strain H. influenzae ATCC 49247 was used as a control.
Biofilm production. Biofilm formation was determined using crystal violet staining as described previously (Mizrahi et al., 2014; Puig et al., 2014b) , with modifications. H. influenzae isolates were cultured on chocolate agar and incubated at 37 C for 24 h with 5 % CO 2 . The isolates were then grown overnight in brain-heart infusion broth (Becton Dickinson) supplemented with NAD and haemin (15 mg l
, haemophilus test medium supplement; Oxoid). The suspension was diluted 1 : 200 in supplemented brain-heart infusion broth, and 200 µl was inoculated into wells of a flat-bottomed polystyrene 96-well microtitre plate (Falcon) and incubated at 37
C for 24 h with 5 % CO 2 . Growth was assessed by measuring optical density absorbance at 595 nm (OD 595 ). Culture media were decanted from the wells, and the remaining planktonic H. influenzae cells were removed by rinsing with distilled water. The wells were air dried, and adhering bacteria were stained with 0.5 % (w/v) crystal violet solution (Sigma-Aldrich) for 20 min. Bound crystal violet was released from H. influenzae cells by a 95 % ethanol solution. Biofilm formation was quantified by OD 595 absorbance measurement. Staphylococcus aureus ATCC 29213 (a high biofilm producer) and Escherichia coli 25922 (a low biofilm producer) were used as controls. The assays were performed in triplicate. Isolates were classified as non-adherent (OD 595 0.120), weakly adherent (OD 595 >0.120-0.240) and strongly adherent (OD 595 >0.240), according to the criteria described elsewhere (Mizrahi et al., 2014) .
Statistical analysis. PFGE data were analysed using the SPSS Statistics 20.0 software (IBM Corporation). PFGE band patterns were generated by LabWorks 4.5 software (Ultra-Violet Products) with 1 % tolerance. Similarity coefficients were generated from a similarity matrix calculated using the Jaccard coefficient.
The chi-squared test with Yates' correction for continuity was applied to compare antimicrobial susceptibility patterns between biofilm-producing and non-producing groups using OpenEpi (Open Source Epidemiologic Statistics for Public Health, version 2.3.1; www.OpenEpi.com, updated 23 June 2011, accessed 25 September 2012). P<0.05 was considered to be significant. APACHE II scores were calculated using the Mediquations Medical Calculator (Mediquations, version 2.03 for Android). These scores were categorized as indicating mild (<9), moderate (9-25) and severe (>25) disease presentations. The Student's t-test and Pearson and Spearman correlations were performed to analyse continuous and ordinal variables. Clinical data management and statistical analysis were performed using R for Windows (version 3.2.2; Lucent Technologies). P<0.05 was considered to be significant, and statistical correlations were considered to be moderate at R 2 >0.40.
RESULTS

Demographic and clinical characteristics
During the 2.5 year study period, a total of 98 NTHi isolates were recovered. Fifty-seven (58.2 %) of these isolates were from tracheal aspirate, 26 (26.5 %) were from sputum and 15 (15.3 %) were from bronchoscopic aspirate specimens. Isolates from 61 (62.3 %) patients were included in the clinical evaluation: data from 27 patients were excluded owing to the inability to collect the necessary information from medical records, and data from 11 patients were excluded owing to the failure to recover strains (contamination or non-viability). The mean age of the 61 patients in the sample was 40.3 years, and these patients were hospitalized mainly for intra-abdominal or lower respiratory tract infections.
None of the patients were subjected to antibacterial prophylaxis. The patients had a median hospital stay of 19.5 days ( Table 1) . The main comorbidities were arterial hypertension and diabetes mellitus. Forty-five percent (n=27) of patients had neurosurgical diagnoses, 45 % (n=27) had respiratory diseases and 10 % (n=7) of patients had other conditions, such as cardiac, renal and non-pulmonary complications.
Clonal diversity PFGE analysis of a randomly selected sample of 25 NTHi isolates revealed 24 distinct types. The analysed isolates showed restriction patterns containing 6 to 14 bands. Only one clone including two isolates (8 %) with identical PFGE patterns was detected (Fig. 1) . The remaining 23 (92 %) isolates had different PFGE types. The percentages of similarity among analysed isolates ranged from 75 % to 100 %.
Antimicrobial susceptibility
The MIC range, MIC 50 and MIC 90 , as well as the percentage of isolates resistant, intermediately resistant and susceptible to each antimicrobial agent tested, are shown in Table 2 . Based on the CLSI interpretive criteria, the H. influenzae isolates presented low resistance to cefotaxime (n=0, 0.0 %), rifampin (n=1, 1.1 %) and chloramphenicol (n=3, 3.2 %). The isolates exhibited greater resistance to ampicillin (n=30, 32.3 %) and trimethoprim-sulfamethoxazole (n=49, 52.7 %). b-Lactamase production was detected in 17.3 % (n=17) of the isolates.
Biofilm production
Only 10 (10.2 %) NTHi isolates formed biofilms. These biofilm-producing isolates were classified as weak (n=8, 80.0 %) and moderate (n=2, 20.0 %); none was classified as a strong biofilm producer. No significant difference in the antimicrobial susceptibility patterns of biofilm producers and non-producers was detected (Table 2) .
Clinical data and biofilm production correlation
Of the study population (n=61), 13 % (n=8) had biofilm-producing isolates, and 87 % (n=53) had nonproducing isolates. Biofilm production ability was not correlated with the severity of clinical presentation (P=0.099), but it was correlated with the length of hospital stay (P=0.05). The mean lengths of stay in the ICU were 30.6 days for patients infected with biofilm-producing isolates and 11.9 days for those infected with nonproducing isolates (Table 1) .
Patients with neurosurgical diagnoses tended to have higher APACHE II scores and thus greater mortality risk ( 
DISCUSSION
Associations between in vitro biofilm formation and NTHi isolates from particular infection types have been reported previously (Obaid et al., 2015) . Biofilm production varies greatly among isolates from different clinical sources, such as otitis media, conjunctivitis, lower respiratory tract infections (in patients with and without cystic fibrosis) and nasopharyngeal carriage.
Greater biofilm production has been reported in patients with otitis media in comparison with non-invasive respiratory infections and the carriage state (Puig et al., 2014a) . Puig et al. (2014a) found that NTHi isolates from patients with invasive disease and otitis media formed denser biofilms, whereas isolates from patients with non-bacteraemic CAP exhibited less capacity for biofilm formation than did all other groups studied. In our study, only 10 % of NTHi isolates were associated with biofilm production, a smaller percentage than observed in a similar study conducted by Obaid et al. (2015) . Our sample was much larger, which could help to explain these contradictory results.
We found no difference in the antimicrobial susceptibility patterns of the biofilm producers and non-producers. Therefore, mechanisms other than the presence of biofilm could be the causes of antimicrobial resistance detected in the NTHi isolates. In our study, H. influenzae isolates showed moderate resistance to ampicillin and trimethoprim-sulfamethoxazole and low resistance to cefotaxime, rifampin and chloramphenicol. The prevalence of b-lactamase in NTHi varies widely throughout the world. In the past decade, percentages of b-lactamase-positive NTHi of 10 and 25 % have been reported in most regions (Murphy, 2003; Alpuche et al., 2007; Sader et al., 2014) , which is similar to our results (17.3 %).
The emergence and spread of b-lactamase-negative, ampicillin-resistant strains in many regions of the world is of substantial concern, as it potentially increases morbidity associated with invasive NTHi infections (Van Eldere et al., 2014) . We detected no b-lactamase-negative, ampicillinresistant strain in this study.
Some studies have analysed NTHi isolates associated with biofilm production involved in acute conditions, such as acute otitis media (Murphy, 2003) . In our study, most cases were associated with subacute to chronic clinical presentations, 36.1 % of which were CAP. A study of correlations between the time of colonization and the ability to produce biofilm in NTHi strains from patients with acute and chronic diseases would be of interest.
In this study, biofilm production ability of NTHi isolates was not correlated with the severity of clinical presentation, as measured directly by the APACHE II score. It was, however, associated with an increased length (+18 days) of hospital stay. This increase may indirectly affect the severity/ mortality of NTHi infections (i.e. deep venous thrombosis/ pulmonary embolism, Clostridium difficile diarrhoea, pneumonia owing to superinfection), in addition to the increment of care costs for comorbidities and complications. To our knowledge, this association has not been reported specifically for NTHi. Therefore, this study may be the first to demonstrate a clinical impact of NTHi biofilm production.
NTHi survival in the host is permitted through virulence factors involved in biofilm and formation and utilization of host proteins as a secondary strategy of increasing the adhesive ability (Duell et al., 2016) . A future deeper analysis of biofilm in NTHi including associated genes, composition and regulation of its production should be of interest.
Our study has several limitations, such as the limited number of isolates examined. Thus, caution should be used when interpreting the results. The main cause for the exclusion of patients was the inability to recover all required information from clinical records, owing to poor-quality data collection (incomplete and/or illegible). Sample size could be improved by designing a template to capture information relevant to the analysis, which would have to be conducted prospectively. Although this study did not include the assessment of patients with relapse or complications attributable to the increased length of hospital stay, not all patients were discharged because of clinical improvement. Therefore, actual morbidity/mortality was not evaluated in this study. We also did not know whether these patients had relapses treated at other healthcare centres. The majority of patients in this study were in the moderate APACHE II group, which included a wide range of scores (9-25). Thus, an improved model should be used to better assess and classify the severity of the clinical course of patients with NTHi.
Analysis of the clonal diversity of NTHi strains indicated a high degree of genetic diversity, which suggests independent colonization and lack of contamination of the materials used for ventilatory support.
Improved surveillance of H. influenzae is needed to evaluate the increasing importance of NTHi as a pathogen in infections of the lower respiratory tract. This surveillance should include comprehensive and standardized monitoring of all cases of invasive H. influenzae disease. In addition, collection of epidemiological data on cases, including demographic details, underlying comorbidities, risk factors and outcomes of infection; accurate identification of the organism by molecular typing methods; and recording of antimicrobial resistance rates and mechanisms of resistance to invasive disease isolates are needed (Van Eldere et al., 2014) .
In conclusion, NTHi isolates obtained from patients with lower respiratory tract infections in Mexico showed low antimicrobial resistance and weak biofilm production. Arterial hypertension and diabetes mellitus were the most common comorbidities. The antimicrobial susceptibility patterns of biofilm-producing and non-producing isolates did not differ. Although biofilm production ability was not associated with the severity of clinical presentation, it was correlated with prolonged hospital stay, which to our knowledge has not been reported specifically for NTHi.
